ReproCELL Future Growth
Future criteria checks 1/6
ReproCELL is forecast to grow earnings and revenue by 7.5% and 15.9% per annum respectively while EPS is expected to grow by 7.6% per annum.
Key information
7.5%
Earnings growth rate
7.6%
EPS growth rate
Biotechs earnings growth | 29.9% |
Revenue growth rate | 15.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 3,350 | -20 | N/A | N/A | 1 |
3/31/2025 | 2,960 | -170 | N/A | N/A | 1 |
3/31/2024 | 2,426 | -31 | -202 | -11 | N/A |
12/31/2023 | 2,506 | -218 | N/A | N/A | N/A |
9/30/2023 | 2,524 | -313 | -274 | -142 | N/A |
6/30/2023 | 2,843 | -275 | N/A | N/A | N/A |
3/31/2023 | 2,953 | -305 | -301 | -140 | N/A |
12/31/2022 | 2,969 | -263 | N/A | N/A | N/A |
9/30/2022 | 2,821 | -306 | -144 | -46 | N/A |
6/30/2022 | 2,518 | -411 | N/A | N/A | N/A |
3/31/2022 | 2,234 | -575 | -294 | -246 | N/A |
12/31/2021 | 1,825 | -505 | N/A | N/A | N/A |
9/30/2021 | 1,661 | -648 | -514 | -440 | N/A |
6/30/2021 | 1,500 | -726 | N/A | N/A | N/A |
3/31/2021 | 1,286 | -812 | -712 | -648 | N/A |
12/31/2020 | 1,257 | -1,011 | N/A | N/A | N/A |
9/30/2020 | 1,249 | -945 | -802 | -673 | N/A |
6/30/2020 | 1,111 | -995 | N/A | N/A | N/A |
3/31/2020 | 1,199 | -1,016 | -829 | -689 | N/A |
12/31/2019 | 1,173 | -834 | N/A | N/A | N/A |
9/30/2019 | 1,114 | -809 | -606 | -540 | N/A |
6/30/2019 | 1,090 | -750 | N/A | N/A | N/A |
3/31/2019 | 1,088 | -601 | -650 | -554 | N/A |
12/31/2018 | 1,046 | -1,950 | N/A | N/A | N/A |
9/30/2018 | 1,018 | -1,965 | -686 | -613 | N/A |
6/30/2018 | 969 | -2,052 | N/A | N/A | N/A |
3/31/2018 | 926 | -2,172 | -679 | -636 | N/A |
12/31/2017 | 1,083 | -1,019 | N/A | N/A | N/A |
9/30/2017 | 1,187 | -759 | N/A | -746 | N/A |
6/30/2017 | 1,202 | -765 | N/A | N/A | N/A |
3/31/2017 | 1,257 | -911 | N/A | -775 | N/A |
12/31/2016 | 1,136 | -1,838 | N/A | N/A | N/A |
9/30/2016 | 1,043 | -2,150 | N/A | -820 | N/A |
6/30/2016 | 1,069 | -2,199 | N/A | N/A | N/A |
3/31/2016 | 1,066 | -1,961 | N/A | -614 | N/A |
12/31/2015 | 1,023 | -791 | N/A | N/A | N/A |
9/30/2015 | 917 | -720 | N/A | -769 | N/A |
6/30/2015 | 743 | -518 | N/A | N/A | N/A |
3/31/2015 | 567 | -451 | N/A | -626 | N/A |
12/31/2014 | 473 | -359 | N/A | N/A | N/A |
9/30/2014 | 463 | -187 | N/A | -108 | N/A |
6/30/2014 | 462 | -140 | N/A | N/A | N/A |
3/31/2014 | 460 | -133 | N/A | -39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6RC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 6RC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 6RC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 6RC's revenue (15.9% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: 6RC's revenue (15.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6RC's Return on Equity is forecast to be high in 3 years time